IMAX China reported FY2025 revenue of USD 102.3 million (FY2024: USD 81.0 million), operating profit of USD 47.2 million (FY2024: USD 27.5 million) and profit attributable to shareholders of USD 37.7 million (FY2024: USD 22.2 million). Basic and diluted EPS were USD 0.11 for FY2025 (FY2024: USD 0.07 basic; USD 0.06 diluted). Cash and cash equivalents were USD 129.9 million as of Dec. 31, 2025 (Dec. 31, 2024: USD 80.0 million), with total assets of USD 377.9 million and total equity of USD 316.0 million. By segment, FY2025 revenue was USD 33.9 million for Content Solutions and USD 66.7 million for Technology Products and Services. The company said it ended 2025 with 810 IMAX theatres in Greater China and 215 theatres in backlog to be installed in a future period, and noted network expansion was limited as customers focused on upgrading existing IMAX theatres to laser technology. IMAX China said the IMAX laser network stood at 202 theatres in Greater China, and that Chinese-language films accounted for 66.4% of its IMAX box office in Chinese Mainland in FY2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IMAX China Holding Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260226-12030001), on February 25, 2026, and is solely responsible for the information contained therein.